7/8/2025CStone Launches Global Phase I/II Trial for Trispecific Antibody CS200...

7/8/2025China Approves 62 Novel Drugs in H1 2025, Led by Small Molecules and A...

7/4/2025CDE Solicits Comments on the 95th Batch of Reference Formulations for ...

7/4/2025CDE Seeks Comment on Revised eCTD Technical Documents and Mapping Tabl...

7/4/2025AstraZeneca Eyes $15B Deal for Summit's Chinese-Developed Lung Cancer ...

7/4/2025Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...

7/4/2025Brii Biosciences Taps Joincare Pharma to Drive BRII‑693 in Greater Ch...

7/4/2025Shaanxi Micot Secures 100M CNY in Series D Financing

7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...

7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...

7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...

7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...

7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders

7/3/2025Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...

7/3/2025Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Million in IPO

7/3/2025Akeso Launches Clinical Trials for First Bispecific ADC

7/3/2025Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Rivals in EGFR Exo...

7/3/2025CStone Expands Pipeline with Novel BsAb Targeting Autoimmune and Infla...

7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...

7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...

7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...

7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...

7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...

7/1/2025Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...

Page:9/56 Total number of articles:1675: [First][<<] [7] [8] [9] [10] [11] [>>] [End]